Vascular Access and Closure recruiting and talent strategy.
Vascular access and closure devices are the tools that get a catheter into a blood vessel and seal it afterward: introducer sheaths and micropuncture kits, closure devices for femoral arteries, large-bore closure for procedures such as TAVR and EVAR, radial access and hemostasis products, and devices for dialysis access. These products are used in nearly every endovascular procedure, so companies sell to cath labs, interventional radiology and vascular surgery alike. (PICC lines, ports and infusion devices sit under vascular access and infusion therapy.)
- MedTech only, since 2001
- 25+ yearsMedTech only, since 2001
- Placements made
- 3,500+Placements made
- We search, listed below
- 4 areasWe search, listed below
Inside vascular access and closure.
A search usually sits in one of these areas, and often spans two or three.
Femoral closure devices
Suture, plug and clip devices that seal the femoral artery after a catheter procedure so patients can walk sooner. Products compete on reliability, ease of use and contract price, so account management and in-service training matter.
- Territory Manager
- Clinical Specialist
- Contracts Manager
- Product Manager
Large-bore access and closure
Sheaths and closure systems for the large holes left by TAVR, EVAR and mechanical circulatory support devices. Complications are costly, so structural and aortic teams evaluate these products carefully.
- Clinical Specialist
- R&D Engineer
- Clinical Research Manager
- Marketing Manager
Radial access
Sheaths, catheters and compression bands for procedures done through the wrist, now common in coronary work and growing in peripheral and neuro procedures. Adoption depends on training labs and nurses as much as physicians.
- Clinical Specialist
- Professional Education Manager
- Territory Manager
- Product Manager
Dialysis access
Devices that create and maintain arteriovenous access for hemodialysis, including endovascular fistula creation and balloons for narrowed access. Customers include vascular surgeons, interventional nephrologists and outpatient vascular access centers.
- Territory Manager
- Reimbursement Manager
- Clinical Specialist
- Medical Science Liaison
Where vascular access and closure searches go wrong.
The assumptions that cost the most time, and what tends to be true instead.
“Closure is a commodity sale”
Price matters, but labs switch when a device is reliable, easy for staff to learn and backed by good training. Reps who run in-services well and keep staff confident hold accounts. Ask candidates how they have won and kept a contract against a cheaper option.
“Large-bore closure is the same as small-bore closure”
Closing a large hole after a valve or aortic case has different risks and buyers. Candidates with structural heart or aortic experience understand those cases and the physicians who perform them.
“Dialysis access is a niche for nephrology reps”
Dialysis access sits between vascular surgery, interventional nephrology and interventional radiology, often in outpatient centers with their own payment rules. Look for candidates who can work across those groups and understand how outpatient access centers operate.
“The most experienced candidate in the therapy area is the safest hire.”
Most companies default to the most experienced candidate, assuming experience equals execution. Early-stage and growth-stage MedTech needs builders, not maintainers, and those are rarely the same person.
Morgan Mills, Sr. Talent Director
Individual contributors to executive leadership.
The same vertical knowledge applies across commercial, clinical, R&D and engineering, regulatory, quality and operations, whether the seat is in the field, the lab, the plant or the boardroom.
- Territory Manager
- Clinical Specialist
- Account Manager
- Professional Education Manager
- Contracts Manager
- R&D Engineer
- Clinical Research Manager
- Medical Science Liaison
- Reimbursement Manager
- Marketing Manager
- Product Manager
Four steps, every time.
The same sequence whether the seat is an engineer, a clinical lead or a territory in vascular access and closure, or the executive who builds the team around them.
- 01Define
A Talent Director who knows your specialty scopes the role, what it has to deliver and the profile that actually wins in your market.
- 02Search & vet
We reach passive candidates others can't, then screen for skill, culture fit and motivation before you see a single resume.
- 03Present
Three to five qualified, interested candidates with our written assessment. Interviews are coordinated for you.
- 04Close & onboard
Offer strategy, counter-offer prep and a 90-day check-in so great hires become long-term ones.
Two ways to work with us in vascular access and closure.
What people ask us about vascular access and closure.
- What is a vascular closure device?
- A vascular closure device seals the puncture in an artery, usually the femoral artery, after a catheter procedure. It replaces or shortens manual pressure so the patient can sit up and walk sooner.
- What is large-bore closure?
- Large-bore closure seals the larger arterial openings used for procedures such as transcatheter valve replacement, endovascular aneurysm repair and mechanical circulatory support. These openings need specialized devices and careful technique.
- Who buys vascular access and closure devices?
- Cath labs, interventional radiology departments and vascular surgery teams use them, and purchasing often goes through hospital value analysis committees and group contracts. Dialysis access devices are also bought by outpatient vascular access centers.
- What background do vascular access and closure candidates usually have?
- Common backgrounds include cath lab and interventional radiology technologists, cardiovascular nurses and sales or clinical roles in interventional cardiology, peripheral vascular or structural heart devices.
More inside peripheral vascular and endovascular.
- Why peripheral vascular companies keep hiring for relationships over ability, and what the best-athlete hiring model looks like in practiceMorgan Mills
- How total compensation in peripheral vascular MedTech has shifted over the past three years, and what the numbers mean for how companies should build their teams nowMorgan Mills
- Why clinical validation is now a commercial strategy decision in cardiovascular and peripheral vascular MedTech, and what happens to adoption when it is treated as an afterthoughtMorgan Mills
- What actually drives EV/EBITDA multiples in cardiovascular and vascular MedTech, and why most founders and operators optimize for the wrong things before a raise or exitMorgan Mills
- The vascular and cardiovascular talent marketNatalie Johnson
Filling seats isn't the objective. The business outcome is.
Tell us what this hire needs to make possible.
We'll bring you the vascular access and closure market before we bring you a shortlist.